Predictive biomarkers of COVID-19 impact in renal transplant patients: an exploratory proteomic and cytokine analysis - Top-Institutions - MDSpire

Predictive biomarkers of COVID-19 impact in renal transplant patients: an exploratory proteomic and cytokine analysis

  • By

  • Ayodele Alaiya

  • Maha Al-Mozaini

  • Zakia Shinwari

  • Abdulaziz Alzayed

  • Ibtihaj Alsharif

  • Rabab Allam

  • Razan Bakheet

  • Layla Alharbi

  • Fahad Ojab Alotaibi

  • Jumana Idris

  • Dalia A. Obeid

  • Abeer Alshukairi

  • Marcela Márquez-Méndez

  • Ricardo M. Cerda-Flores

  • Hamad A. Almojalli

  • June 12, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Icahn School of Medicine at Mount Sinai/The Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/The Mount Sinai Hospital

    New York, New York

    Key Differentiators

    • Nephrology
    • Transplant Surgery

  • #2

    Columbia University Irving Medical Center/NewYork-Presbyterian Hospital
    Columbia University Irving Medical Center/NewYork-Presbyterian Hospital

    New York, New York

    Key Differentiators

    • Nephrology
    • Transplant Surgery

Original Source(s)

Predictive biomarkers of COVID-19 impact in renal transplant patients: an exploratory proteomic and cytokine analysis

  • by Ayodele Alaiya, Maha Al-Mozaini, Zakia Shinwari, Abdulaziz Alzayed, Ibtihaj Alsharif, Rabab Allam, Razan Bakheet, Layla Alharbi, Fahad Ojab Alotaibi, Jumana Idris, Dalia A. Obeid, Abeer Alshukairi, Marcela Márquez-Méndez, Ricardo M. Cerda-Flores, Hamad A. Almojalli

  • June 12, 2026

Related Content

Assessing the association of physical distancing to avoid COVID-19 with health-related quality of life in immunocompromised adolescents: results from the cross-sectional observational EAGLE study

How long Covid’s scientific stalemate made it politically erasable

Early Immunological Biomarkers for Personalized Treatment Selection in Severe COVID-19: Post Hoc Machine Learning Analysis of a Randomized Clinical Trial